Evidence map›Paper›PMID 25089886›Full record

ArticleDNA repair2014

Sgs1 and Exo1 suppress targeted chromosome duplication during ends-in and ends-out gene targeting.

Anamarija Štafa, Marina Miklenić, Bojan Zunar, Berislav Lisnić, Lorraine S Symington, Ivan-Krešimir Svetec

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel Approach in the Construction of 
Bioethanol-ProducingFood technology and biotechnology · 2019
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anamarija ŠtafaLaboratory for Biology and Microbial Genetics, Department of Biochemical Engineering, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb 10000, Croatia; Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: astafa@pbf.hr.
Marina MiklenićLaboratory for Biology and Microbial Genetics, Department of Biochemical Engineering, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb 10000, Croatia.
Bojan ZunarLaboratory for Biology and Microbial Genetics, Department of Biochemical Engineering, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb 10000, Croatia.
Berislav LisnićLaboratory for Biology and Microbial Genetics, Department of Biochemical Engineering, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb 10000, Croatia.
Lorraine S SymingtonDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA.
Ivan-Krešimir SvetecLaboratory for Biology and Microbial Genetics, Department of Biochemical Engineering, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb 10000, Croatia. Electronic address: iksvetec@pbf.hr.
University of Zagreb · HRColumbia University Irving Medical Center · US

Funding

Break-induced replication and genome rearrangementsR01GM094386 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SYMINGTON, LORRAINE S · 2010 to 2017
$2.4M
NIGMS NIH HHS R01 GM094386
6 · The paper itself

Abstract

Gene targeting is extremely efficient in the yeast Saccharomyces cerevisiae. It is performed by transformation with a linear, non-replicative DNA fragment carrying a selectable marker and containing ends homologous to the particular locus in a genome. However, even in S. cerevisiae, transformation can result in unwanted (aberrant) integration events, the frequency and spectra of which are quite different for ends-out and ends-in transformation assays. It has been observed that gene replacement (ends-out gene targeting) can result in illegitimate integration, integration of the transforming DNA fragment next to the target sequence and duplication of a targeted chromosome. By contrast, plasmid integration (ends-in gene targeting) is often associated with multiple targeted integration events but illegitimate integration is extremely rare and a targeted chromosome duplication has not been reported. Here we systematically investigated the influence of design of the ends-out assay on the success of targeted genetic modification. We have determined transformation efficiency, fidelity of gene targeting and spectra of all aberrant events in several ends-out gene targeting assays designed to insert, delete or replace a particular sequence in the targeted region of the yeast genome. Furthermore, we have demonstrated for the first time that targeted chromosome duplications occur even during ends-in gene targeting. Most importantly, the whole chromosome duplication is POL32 dependent pointing to break-induced replication (BIR) as the underlying mechanism. Moreover, the occurrence of duplication of the targeted chromosome was strikingly increased in the exo1Δ sgs1Δ double mutant but not in the respective single mutants demonstrating that the Exo1 and Sgs1 proteins independently suppress whole chromosome duplication during gene targeting.

Indexed as

Chromosome DuplicationGene TargetingDNA Breaks, Double-StrandedDNA-Directed DNA PolymeraseDNA ReplicationExodeoxyribonucleasesHomologous RecombinationRecQ HelicasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsDNA-Directed DNA Polymeraseexodeoxyribonuclease IExodeoxyribonucleasesPol32 protein, S cerevisiaeRecQ HelicasesSaccharomyces cerevisiae ProteinsSGS1 protein, S cerevisiaeBreak-induced replicationEnds-inEnds-outGene targetingHomologous recombinationWhole chromosome duplication

Identifiers

PMID25089886
PMCPMC4175061
OpenAlexW2107628021

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.